David Chang

5.2k total citations
68 papers, 2.9k citations indexed

About

David Chang is a scholar working on Oncology, Cardiology and Cardiovascular Medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, David Chang has authored 68 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Oncology, 20 papers in Cardiology and Cardiovascular Medicine and 15 papers in Pulmonary and Respiratory Medicine. Recurrent topics in David Chang's work include Colorectal Cancer Treatments and Studies (13 papers), Pancreatic and Hepatic Oncology Research (10 papers) and Cardiac pacing and defibrillation studies (9 papers). David Chang is often cited by papers focused on Colorectal Cancer Treatments and Studies (13 papers), Pancreatic and Hepatic Oncology Research (10 papers) and Cardiac pacing and defibrillation studies (9 papers). David Chang collaborates with scholars based in United States, China and Australia. David Chang's co-authors include Huamin Wang, Cathy Eng, Lee M. Ellis, Daria Zorzi, Dario Ribero, Eddie K. Abdalla, Steven A. Curley, Laurence M. Epstein, Robert A. Wolff and Lorenzo Cohen and has published in prestigious journals such as Journal of Clinical Oncology, Gastroenterology and Journal of the American College of Cardiology.

In The Last Decade

David Chang

63 papers receiving 2.9k citations

Peers

David Chang
Kazuhiro Katayama Japan
Bin Sun China
Hiroaki Kanda Japan
Eiji Uchida Japan
Wolfgang E. Thasler Germany
Matthias S. Matter Switzerland
Fabio Maria Vecchio Italy
Bei Zhang China
Federica Grillo Italy
Jun Itakura Japan
Kazuhiro Katayama Japan
David Chang
Citations per year, relative to David Chang David Chang (= 1×) peers Kazuhiro Katayama

Countries citing papers authored by David Chang

Since Specialization
Citations

This map shows the geographic impact of David Chang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Chang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Chang more than expected).

Fields of papers citing papers by David Chang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Chang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Chang. The network helps show where David Chang may publish in the future.

Co-authorship network of co-authors of David Chang

This figure shows the co-authorship network connecting the top 25 collaborators of David Chang. A scholar is included among the top collaborators of David Chang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Chang. David Chang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kim, Tommy, et al.. (2025). The efficacy of postoperative visits for detecting complications in pediatric patients. Surgery. 181. 109158–109158.
2.
Saleh, Moussa, James Gabriels, David Chang, et al.. (2020). Safely Administering Potential QTc Prolonging Therapy Across a Large Health Care System in the COVID-19 Era. Circulation Arrhythmia and Electrophysiology. 13(11). e008937–e008937. 8 indexed citations
3.
Saleh, Moussa, James Gabriels, David Chang, et al.. (2020). Effect of Chloroquine, Hydroxychloroquine, and Azithromycin on the Corrected QT Interval in Patients With SARS-CoV-2 Infection. Circulation Arrhythmia and Electrophysiology. 13(6). e008662–e008662. 218 indexed citations
4.
Collier, Amber L., Dasom Lee, Richard Hoefer, et al.. (2020). Perspectives on Triple-Negative Breast Cancer: Current Treatment Strategies, Unmet Needs, and Potential Targets for Future Therapies. Cancers. 12(9). 2392–2392. 229 indexed citations
5.
Chang, David, James Gabriels, Beom Soo Kim, et al.. (2020). Electrocardiographic localization of ventricular arrhythmias successfully ablated from the distal great cardiac vein. Journal of Cardiovascular Electrophysiology. 31(10). 2668–2676.
6.
Gabriels, James, David Chang, Melanie Maytin, et al.. (2020). Percutaneous management of superior vena cava syndrome in patients with cardiovascular implantable electronic devices. Heart Rhythm. 18(3). 392–398. 16 indexed citations
7.
Chang, David, Moussa Saleh, James Gabriels, et al.. (2020). Inpatient Use of Ambulatory Telemetry Monitors for COVID-19 Patients Treated With Hydroxychloroquine and/or Azithromycin. Journal of the American College of Cardiology. 75(23). 2992–2993. 45 indexed citations
8.
Maurer, Lydia R., Megan E. Barra, Majed El Hechi, et al.. (2020). A low dose heparinized saline protocol is associated with improved duration of arterial line patency in critically ill COVID-19 patients. Journal of Critical Care. 60. 253–259. 7 indexed citations
9.
Chang, David, et al.. (2019). A novel diagnostic approach to a mass on a device lead. HeartRhythm Case Reports. 5(6). 306–309. 6 indexed citations
10.
11.
Iannuzzi, James C., Sahael M. Stapleton, Yanik J. Bababekov, et al.. (2018). Favorable impact of thoracic endovascular aortic repair on survival of patients with acute uncomplicated type B aortic dissection. Journal of Vascular Surgery. 68(6). 1649–1655. 64 indexed citations
12.
Li, Ming, Laszlo Radvanyi, Bingnan Yin, et al.. (2017). Downregulation of Human Endogenous Retrovirus Type K (HERV-K) Viral env RNA in Pancreatic Cancer Cells Decreases Cell Proliferation and Tumor Growth. Clinical Cancer Research. 23(19). 5892–5911. 98 indexed citations
13.
Laquente, Berta, José A. López-Martín, Donald Richards, et al.. (2017). A phase II study to evaluate LY2603618 in combination with gemcitabine in pancreatic cancer patients. BMC Cancer. 17(1). 137–137. 53 indexed citations
14.
15.
Gao, Yong, Zhiliang Jia, Xiangyu Kong, et al.. (2011). Combining Betulinic Acid and Mithramycin A Effectively Suppresses Pancreatic Cancer by Inhibiting Proliferation, Invasion, and Angiogenesis. Cancer Research. 71(15). 5182–5193. 85 indexed citations
16.
Jia, Zhiliang, Yong Gao, Liwei Wang, et al.. (2010). Combined Treatment of Pancreatic Cancer with Mithramycin A and Tolfenamic Acid Promotes Sp1 Degradation and Synergistic Antitumor Activity. Cancer Research. 70(3). 1111–1119. 63 indexed citations
17.
Meng, Zhiqiang, Peiying Yang, Yehua Shen, et al.. (2009). Pilot study of huachansu in patients with hepatocellular carcinoma, nonsmall‐cell lung cancer, or pancreatic cancer. Cancer. 115(22). 5309–5318. 246 indexed citations
18.
Ribero, Dario, Huamin Wang, Matteo Donadon, et al.. (2007). Bevacizumab improves pathologic response and protects against hepatic injury in patients treated with oxaliplatin‐based chemotherapy for colorectal liver metastases. Cancer. 110(12). 2761–2767. 278 indexed citations
19.
Tsuda, Naotake, Satoshi Ishiyama, Yufeng Li, et al.. (2006). Synthetic MicroRNA Designed to Target Glioma-Associated Antigen 1 Transcription Factor Inhibits Division and Induces Late Apoptosis in Pancreatic Tumor Cells. Clinical Cancer Research. 12(21). 6557–6564. 64 indexed citations
20.
Chang, David & James L. Abbruzzese. (2005). Capecitabine plus oxaliplatin vs infusional 5-fluorouracil plus oxaliplatin in the treatment of colorectal cancer. Pro: The CapeOx regimen is preferred over FOLFOX.. PubMed. 3(5). 400–4. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kazuhiro Katayama Breakdown of academic impact, for papers by Bin Sun Breakdown of academic impact, for papers by Hiroaki Kanda Breakdown of academic impact, for papers by Eiji Uchida Breakdown of academic impact, for papers by Wolfgang E. Thasler Breakdown of academic impact, for papers by Matthias S. Matter Breakdown of academic impact, for papers by Fabio Maria Vecchio Breakdown of academic impact, for papers by Bei Zhang Breakdown of academic impact, for papers by Federica Grillo Breakdown of academic impact, for papers by Jun Itakura
Rankless by CCL
2026